MARK NEAL HENDRIXSON MD NPI 1457469223

NPI Information

  • NPI: 1457469223
  • Provider Name: MARK NEAL HENDRIXSON, MD
  • Classification: Internal Medicine - 207RX0202X
  • Specialization: Medical Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 707 S MAIN ST
    CROSSVILLE, TN
    ZIP 38555
  • Phone: (931) 456-8435

Map and Directions

Get Directions

NPI Details

Mark Neal Hendrixson, MD is a medical oncology internal medicine in Crossville, TN with 36 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. Mark Neal Hendrixson, MD NPI is 1457469223. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF TENNESSEE, HSC, COLLEGE OF MEDICINE
Graduation Year:1990

The provider's business location address is:

707 S MAIN ST
CROSSVILLE, TN
ZIP 38555-011
Phone: (931) 456-8435
Fax: (931) 456-8496

The NPI 1457469223 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
  • Injection, paclitaxel, 1 mg (HCPCS:J9267)
  • Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Amylase (enzyme) level (HCPCS:82150)
  • Total protein level, blood (HCPCS:84155)
  • Liver enzyme (sgot), level (HCPCS:84450)
  • Liver enzyme (sgpt), level (HCPCS:84460)
  • Bilirubin level, total (HCPCS:82247)
  • Albumin (protein) level (HCPCS:82040)
  • Phosphatase (enzyme) level, alkaline (HCPCS:84075)
  • Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
  • Glutamyltransferase (liver enzyme) level (HCPCS:82977)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Drawing of blood for a medical problem (HCPCS:99195)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Irrigation of implanted venous access drug delivery device (HCPCS:96523)
  • New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
  • Collection of blood sample from implanted device (HCPCS:36591)

The enumeration date for this NPI number is 8/29/2006 and was last updated on 7/24/2023.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RX0202XInternal MedicineMedical OncologyMD021724TENNESSEEYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
14096802OTHERTENNESSEEBCBS
23091500MEDICAIDTENNESSEE
39958819OTHERTENNESSEECIGNA

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.